ANXA1 and gestational diabetes: These findings suggest that psEVs may regulate insulin synthesis during pregnancy, possibly through ANXA1 upregulation, contributing to improved β-cell function in pregnant women and offering insights for future therapeutic strategies in managing gestational diabetes mellitus (GDM).